Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy [PDF]
Erythema nodosum is a septal panniculitis that typically presents as symmetric, tender nodules on the anterior aspects of bilateral lower extremities.
Michelle S. Min +2 more
doaj +2 more sources
Norethindrone Acetate in the Medical Management of Adenomyosis [PDF]
The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27–49 years of age presenting with moderate to severe pelvic pain and bleeding.
Siddhi Mankame +4 more
doaj +2 more sources
Use of Oral Gonadotropin Releasing Hormone Antagonist Combinations for Preoperative Management of Refractory Leiomyoma-Related Heavy Menstrual Bleeding [PDF]
Uterine leiomyomas are noncancerous smooth muscle neoplasms that occur in up to 70% of women and the single most common cause of hysterectomy. There is a variety of treatments available for uterine leiomyomas, including medications, uterine artery ...
Danielle A. Aase, Elizabeth A. Stewart
doaj +2 more sources
Medical management of recurrent endometrioma with long-term norethindrone acetate
Ozgul Muneyyirci-Delale1,2, Jenny Anopa1, Cassandra Charles1, Deepali Mathur1, Rudolph Parris1, Jed B Cutler2, Ghadir Salame1,2, Ovadia Abulafia1,21Department of Obstetrics and Gynecology, SUNY Downstate Medical Center, New York, NY, USA; 2Department of ...
Muneyyirci-Delale O +7 more
doaj +3 more sources
Progestin Pollution in Surface Waters of a Major Southwestern European Estuary: The Douro River Estuary (Iberian Peninsula) [PDF]
The concentrations and spreading of eight synthetic and two natural progestins (PGs) were investigated in surface waters from ten sites at the Douro River Estuary.
Frederico Silva +3 more
doaj +2 more sources
Safety and efficacy of relugolix combination therapy in symptomatic uterine fibroids [PDF]
Background: Relugolix-combination therapy (CT) (oestradiol 1 mg and norethindrone acetate 0.5 mg) is a new gonadotropin-releasing hormone antagonist licensed to treat heavy menstrual bleeding (HMB) associated with uterine fibroids; but little real-world ...
Maria Chiara De Angelis +7 more
doaj +2 more sources
The effect of low-dose combined hormone therapy (oestradiol and norethindrone acetate) on serum C-reactive protein levels and life quality in natural menopause women [PDF]
Servin Gocer +3 more
doaj +2 more sources
A Comparative Metabolomics Study of the Potential Marker Compounds in Feces from Different Hybrid Offspring of Huainan Pigs [PDF]
As a notable native Chinese genetic population, the Huainan pig has an exceptional meat quality but a low percentage of lean meat and subpar genetic performance.
Yufu Li +8 more
doaj +2 more sources
Relugolix–Estradiol–Norethindrone Acetate (Myfembree)
Canada’s Drug Agency (CDA-AMC) recommends that Myfembree should be reimbursed by public drug plans for the treatment of heavy menstrual bleeding (HMB) from uterine fibroids (UFs) in patients in the premenopausal stage if certain conditions are met. Myfembree should only be covered to treat patients who are aged 18 years or older who have HMB from ...
CDA-AMC
openaire +3 more sources

